Upadacitinib in Moderate-to-Severe Atopic Dermatitis: Real-Life Study of Long-Term Efficacy, Safety and Correlation Between Clinical Effectiveness and Subjective Perception of Disease

被引：1
|
作者：
Bertello, M. [1 ]
Cinotti, E. [1 ]
Rubegni, P. [1 ]
Mastorino, L. [2 ]
Passaro, G. [2 ]
Ortoncelli, M. [2 ]
Quaglino, P. [2 ]
Ribero, S. [2 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurol Sci, Dermatol Unit, Siena, Italy
[2] Univ Turin, Med Sci Dept, Dermatol Clin, Turin, Italy
来源：
DERMATITIS | 2024年
关键词：
D O I：
10.1089/derm.2024.0346
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Upadacitinib effectiveness in moderate-to-severe atopic dermatitis: A real-life multicentre and retrospective study
    Ramos, F. Javier Melgosa
    Gonzalez-Delgado, Victor
    Motilla, Jose Maria Sanchez
    Marta, Galarreta Pascual
    Mateu Puchades, Almudena
    Sergio, Santos Alarcon
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e361 - e364
  • [2] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [3] Real-life efficacy and safety of upadacitinib in adolescents with moderate-to-severe atopic dermatitis unresponsive to dupilumab: A case series
    Patruno, Cataldo
    Fabbrocini, Gabriella
    Potestio, Luca
    Genco, Lucia
    Napolitano, Maddalena
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (07) : E901 - E903
  • [4] Assessment of long-term safety and efficacy of Dupilumab therapy in patients with moderate-to-severe atopic dermatitis in the UAE: A real-life observational study
    Abdulwahhab, Waqas S.
    Zainalabdin, Sham
    Al-Areqi, Noor
    Amrane, Imene
    Alhashmi, Ahmed
    Aburuz, Omar
    Akour, Amal
    Beiram, Rami
    Aburuz, Salahdein
    PHARMACY PRACTICE-GRANADA, 2024, 22 (02):
  • [5] Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Salman, Andac
    Sengun, Ozlem Apti
    Aktas, Meryem
    Taskapan, Oktay
    DERMATOLOGIC THERAPY, 2022, 35 (01)
  • [6] Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study
    Leo, Francesco
    Ortoncelli, Michela
    Cascio Ingurgio, Ruggero
    Galli, Benedetta
    Grigolato, Laura
    Paganini, Claudia
    Maurelli, Martina
    Di Brizzi, Eugenia Veronica
    Lauletta, Giuseppe
    Barei, Francesca
    Fiasconaro, Chiara Anna
    Casale Alloa, Marta
    Guanti, Mario Bruno
    Gori, Niccolo
    Chiricozzi, Andrea
    Napolitano, Maddalena
    Patruno, Cataldo
    Galluzzo, Marco
    Rossi, Mariateresa
    Balato, Anna
    Ferrucci, Silvia Mariel
    Marzano, Angelo Valerio
    Pezzolo, Elena
    Foti, Caterina
    Girolomoni, Giampiero
    Gargiulo, Luigi
    Narcisi, Alessandra
    Quaglino, Pietro
    Ribero, Simone
    Mastorino, Luca
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025,
  • [7] Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
    Luigi Gargiulo
    Luciano Ibba
    Andrea Cortese
    Jessica Avagliano
    Mario Valenti
    Antonio Costanzo
    Alessandra Narcisi
    Dermatology and Therapy, 2023, 13 : 651 - 660
  • [8] Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study
    Gargiulo, Luigi
    Ibba, Luciano
    Cortese, Andrea
    Avagliano, Jessica
    Valenti, Mario
    Costanzo, Antonio
    Narcisi, Alessandra
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 651 - 660
  • [9] Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Fargnoli, M. C.
    Esposito, M.
    Ferrucci, S.
    Girolomoni, G.
    Offidani, A.
    Patrizi, A.
    Peris, K.
    Costanzo, A.
    Malara, G.
    Pellacani, G.
    Romanelli, M.
    Amerio, P.
    Cristaudo, A.
    Flori, M. L.
    Motolese, A.
    Betto, P.
    Patruno, C.
    Pigatto, P.
    Sirna, R.
    Stinco, G.
    Zalaudek, I.
    Bianchi, L.
    Boccaletti, V.
    Cannavo, S. P.
    Cusano, F.
    Lembo, S.
    Mozzillo, R.
    Gallo, R.
    Potenza, C.
    Rongioletti, F.
    Tiberio, R.
    Grieco, T.
    Micali, G.
    Persechino, S.
    Pettinato, M.
    Pucci, S.
    Savi, E.
    Stingeni, L.
    Romano, A.
    Argenziano, G.
    Calabrese, Giulia
    Campanati, Anna
    Caruso, Cristiano
    Chello, Camilla
    De Pasquale, Tiziana
    Di Costanzo, Luisa
    Dini, Valentina
    De Pasquale, Rocco
    Del Giglio, Micol
    Fracassi, Giovanna
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2021, 32 (05) : 507 - 513
  • [10] Real-life long-term efficacy of dupilumab in adults with moderate to severe atopic dermatitis: Results of a cohort study
    Guedon, C.
    Tauber, M.
    Linder, C.
    Paul, C.
    Shourick, J.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2023, 150 (03): : 215 - 216
12345